https://slaynews.com/news/cleveland-clinic-flu-vaccines-slash-life-expectancy/

Cleveland Clinic: Flu ‘Vaccines’ Slash Life Expectancy

A damning new study from the world-renowned Cleveland Clinic has confirmed that flu “vaccines” slash overall life expectancy by increasing the chance of being infected with influenza.

The study found that people who received the seasonal shots have a 26.9% higher chance of getting the flu compared to the unvaccinated.

The findings of the study were highlighted by esteemed British immunologist  Dr. John Campbell.

In a video shared on his YouTube channel, Dr. Campbell explains:

“A large study at the Cleveland Clinic found out that the flu ‘vaccine’ – the influenza ‘vaccine’ – over the last Winter, wasn’t that effective.

“In fact, it had a negative efficacy of 26.9%.

“In other words, if you took this flu vaccine, you were 26.9% more likely – more likely – to get influenza.

“Now, unfortunately, the paper doesn’t give us details on how much money the pharmaceutical industry made from selling this ‘vaccine’ with negative efficacy.”

Big Pharma makes $6.3 billion annually on this “vaccine.”
(See link for article)
__________________
 
**Comment**
  • A Pentagon study by Wolfe revealed that those vaccinated against the flu were “36% more likely to get coronavirus.
  • Secretary Robert F. Kennedy Jr. warned in March that people who receive flu “vaccines” are “4.4 times more likely” to suffer a non-influenza infection.
  • Originally, the flu vaccine was a measure to protect the elderly, but go here for a blast from the past when four scientists researching the Flu vaccine during the 1960s found it to be ineffective and refused to give it to their own families.  The scientists state they were prevented from publishing their negative findings.
  • Now a recent Japanese study shows NO BENEFIT on hard outcomes: hospitalization and death. Another perfect example of how the massive push to vaccinate people for the flu has been a waste of time and effort.  Do not expect to read about this in the news.
  • The flu vaccine doesn’t prevent the spread of the flu.
  • CDC admits flu vaccine failed 91% of the time against the current flu strain.
  • Cochran’s 2018 review of 52 clinical studies on flu vaccines found only 15% of the studies were well designed and conducted and concluded that recommendations for routine use of influenza vaccine as a routine public health measure was not supported by the published evidence base.  
Yet, despite all evidence, DHHS is unveiling a ‘Universal Flu Vaccine.’

https://thevaccinereaction.org/2025/05/universal-flu-vaccine-unveiled-by-dhhs/

“Universal Flu Vaccine” Unveiled by DHHS

“Universal Flu Vaccine” Unveiled by DHHS

On May 1, 2025, the U.S. Department of Health and Human Services (DHHS) announced plans to develop a universal influenza vaccine that would eliminate the need for annual flu shots and offer protection against other pandemic influenza threats, including bird flu and respiratory disease caused by coronaviruses. The initiative, called “Generation Gold Standard,” will cost $500 million and reportedly combine “traditional vaccine technology” with modern tools. The “traditional” vaccine technology, called a beta-propiolactone (BPL)-inactivated, whole-virus platform, involves injecting people with a chemically altered version of the whole virus designed to make it harmless but still capable of stimulating the immune system.1 2 3

The announcement follows a recent study out of the Cleveland Clinic that found this year’s flu shot for the 2024-2025 flu season to be -26.9 percent effective and linked to an increased risk of influenza compared to unvaccinated individuals

“Generation Gold Standard is a paradigm shift,” said U.S. National Institutes of Health (NIH) director Jay Bhattacharya, MD, PhD. “It extends vaccine protection beyond strain-specific limits and prepares for flu viral threats—not just today’s, but tomorrow’s as well—using traditional vaccine technology brought into the 21st century.”1

The Generation Gold Standard initiative was made public the day after the DHHS announced that all newly developed vaccines will be required to undergo placebo-controlled clinical trials before receiving licensure. “Our commitment is clear: every innovation in vaccine development must be grounded in gold standard science and transparency, and subjected to the highest standards of safety and efficacy testing,” said DHHS Secretary Robert F. Kennedy, Jr.4

Some researchers questioned the decision to rely on what they consider an outdated and potentially inadequate approach. “This is a head-scratcher to me. This is puzzling,” Gregory Poland, MD, a vaccine expert from the Atria Academy of Science and Medicine in New York, told NPR. “We’re going back to technology that was used 40, 50 years ago or more. So this is a little surprising to me why you would go backwards to this technology? It’s a very old technology,” Poland says. “This is what influenza vaccines in the 40s, 50s and 60s looked like.”2

Dr. Poland suggested that newer technologies, such as the mRNA-based COVID shots, are safer and produce fewer side effects compared to whole inactivated virus vaccines, which he says typically produce high fevers and seizures and potentially scare patients away from getting vaccinated. “We have live attenuated nasal spray influenza vaccines. We have recombinant influenza vaccines. We have an mRNA-based influenza vaccine,” he says. “So why would you put all your eggs in one basket?”2

Researchers Warn of Underreported Injuries, Push for mRNA Vaccine Pause

While some experts criticize this approach as outdated, whole-virus vaccines, compared to mRNA (messenger ribonucleic acid) biologics technology, have been in use for decades and have well-documented safety profiles.5 Meanwhile, mRNA biologics have been at the center of ongoing controversy and public concern since mRNA COVID shots were approved for distribution by the FDA in December 2020.6

A 2024 study published in The Journal of American Physicians and Surgeons suggests that COVID-19 shots should never have been classified as vaccines in the first place. “COVID-19 modRNA vaccines were misclassified as traditional vaccines rather than gene therapy products, bypassing stricter regulatory requirements; and WHO guidelines from 2005 were used for nonclinical assessments, despite being outdated and inapplicable to modRNA vaccines,” epidemiologist Nicolas Hulscher, MPH said in a Substack post discussing the study findings.7 8  (See link for article)

______________

**Comment**

This ‘universal vaccine’ could enter clinical trials as early as next year and will be available to the public by 2029.  

For more: